| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $11.6B | — | $4.2B | — | 176.0% |
| Op. Income | $2.0B | — | -$803M | — | 353.7% |
| Gross Margin | 46.5% | — | 27.0% | — | 19.5pp |
| Net Margin | 15.6% | — | -16.9% | — | 32.5pp |
| EPS (Diluted) | $7.57 | — | $-4.55 | — | 266.4% |
| Free Cash Flow | $1.8B | — | $8M | — | 22887.5% |
| Item | Amount |
|---|---|
| REVENUE | $11.6B |
| Cost of Revenue | $6.2B |
| GROSS PROFIT | $5.4B |
| R&D Expenses | $0 |
| Selling & Marketing | $3.2B |
| General & Administrative | $181M |
| SG&A Expenses | $3.3B |
| Other Expenses | $40M |
| Operating Expenses | $3.4B |
| Cost & Expenses | $9.6B |
| OPERATING INCOME | $2.0B |
| Interest Income | $0 |
| Interest Expense | $235M |
| Other Income/Expenses | $245M |
| INCOME BEFORE TAX | $2.3B |
| Income Tax Expense | $463M |
| NET INCOME | $1.8B |
| D&A | $3.0B |
| EBIT | $2.0B |
| EBITDA | $5.0B |
| EPS | $8 |
| EPS Diluted | $8 |
| Item | Amount |
|---|---|
| REVENUE | $11.6B |
| Cost of Revenue | $6.2B |
| GROSS PROFIT | $5.4B |
| R&D Expenses | $0 |
| Selling & Marketing | $3.2B |
| General & Administrative | $181M |
| SG&A Expenses | $3.3B |
| Other Expenses | $40M |
| Operating Expenses | $3.4B |
| Cost & Expenses | $9.6B |
| OPERATING INCOME | $2.0B |
| Interest Income | $0 |
| Interest Expense | $235M |
| Other Income/Expenses | $245M |
| INCOME BEFORE TAX | $2.3B |
| Income Tax Expense | $463M |
| NET INCOME | $1.8B |
| D&A | $3.0B |
| EBIT | $2.0B |
| EBITDA | $5.0B |
| EPS | $8 |
| EPS Diluted | $8 |
| Item | Amount |
|---|---|
| Net Income | $1.8B |
| Depreciation & Amortization | $3.0B |
| Stock-Based Compensation | $46M |
| Deferred Income Tax | $448M |
| Other Non-Cash Items | -$433M |
| Change in Working Capital | -$285M |
| OPERATING CASH FLOW | $4.6B |
| Capital Expenditure | -$2.7B |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$14M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$9M |
| NET CASH FROM INVESTING | -$2.8B |
| Net Debt Issuance | -$663M |
| Common Stock Repurchased | -$100M |
| Common Dividends Paid | -$765M |
| Other Financing Activities | -$11M |
| NET CASH FROM FINANCING | -$1.5B |
| FREE CASH FLOW | $1.8B |
| Net Change in Cash | $301M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $696M |
| Short-Term Investments | $264M |
| Net Receivables | $1.6B |
| Inventory | $0 |
| Other Current Assets | $357M |
| TOTAL CURRENT ASSETS | $2.9B |
| PP&E (Net) | $24.4B |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $360M |
| Tax Assets | $168M |
| Other Non-Current Assets | $488M |
| TOTAL NON-CURRENT ASSETS | $25.4B |
| TOTAL ASSETS | $28.3B |
| Account Payables | $753M |
| Short-Term Debt | $51M |
| Deferred Revenue | $1.2B |
| Other Current Liabilities | $608M |
| TOTAL CURRENT LIABILITIES | $2.9B |
| Long-Term Debt | $5.0B |
| Deferred Revenue NC | $975M |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $824M |
| TOTAL NON-CURRENT LIABILITIES | $6.8B |
| TOTAL LIABILITIES | $9.7B |
| Common Stock | $2M |
| Additional Paid-In Capital | $13.7B |
| Retained Earnings | $4.8B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $18.6B |
| Minority Interest | $0 |
| TOTAL EQUITY | $18.6B |
| TOTAL LIABILITIES & EQUITY | $28.3B |
| Total Debt | $5.1B |
| Net Debt | $4.4B |
